In summary, our present study provided evidence that BMP6 is a potential target for overcoming MDR in breast cancer, and GA5 could overcome MDR by increasing BMP6 expression, suggesting that GA5 had the potential in the treatment of multidrug resistant breast cancer. The gene discussed is BMP6; the disease is breast carcinoma.